Medpace Holdings, Inc. (MEDP) is a leading global full-service clinical contract research organization (CRO), providing comprehensive development services for drug, biologic, and medical device companies. Founded in 1992, the company's headquarters are located in Cincinnati, Ohio. Medpace Holdings, Inc. is publicly traded on the NASDAQ Stock Market under the ticker symbol 'MEDP'.
The organization's main purpose is to accelerate the global development of safe and effective medical therapeutics. Medpace accomplishes this by leveraging its scientific expertise in various therapeutic areas, such as oncology, cardiovascular diseases, metabolic diseases, and many others. The company conducts clinical trials in all phases (I-IV), collaborates on regulatory strategies, and oversees trial data management and analysis.
In addition to clinical research services, Medpace provides centralized laboratory services, imaging services, and clinical pharmacology services. It works with a vast range of organizations, from ambitious start-ups to larger multinational enterprises. Medpace prides itself on its therapeutic and regulatory expertise, combining it with practical operational ability to manage studies in over 50 countries.
Medpace stands out for its unique physician-led, integrated approach to conducting clinical trials. This method helps to streamline the development process and provides higher-quality results, helping their clients to bring products to market faster and more efficiently. Medpace's team of medical doctors, Ph.D. level scientists and coordinators contribute to Medpace’s reputable client-focused service.
It is also noteworthy that Medpace is committed to maintaining the highest level of professional and ethical standards. The company follows the guidelines set forth by Good Clinical Practice (GCP), International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), and other regulatory authorities.
In recent years Medpace has expanded organically as well as through strategic acquisitions to further enhance their service offerings and global footprints. The company continues to thrive and evolve in the ever-changing landscape of clinical research.
Medpace's wide range of services, dedication to quality, and continuous growth mark them as a key player in the CRO industry. Their work helps facilitate the development and approval of new medicines and medical devices, playing a vital role in improving global healthcare.